UNI-EN 19:Sopharma monthly feb 2012
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
| | UNI - EN REPORT No | 19 | / | 2012 | | ||||||
| Date of issue: | 2012-03-05 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Sopharma monthly feb 2012 | |||||||||||
| Official market - legal basis | |||||||||||
| Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Dear Sir or Madam, In compliance with art. 100k., para. 1 from the POSA, we would like to notify that for the month of February, 2012 Sopharma AD realized growth of sales revenues of 20% compared with the same month of the previous year, including 10% decrease of domestic sales 33% growth of export sales. From the beginning of this year sales revenues increased with 3%, including 23% decrease of domestic sales and 13 % growth of export sales. In accordance with the provisions of art. 100 k., para. 1 from the POSA, please make the aforementioned information public. 05.03.2012 Pelagia Viatcheva /IR Director, Sopharma AD/ | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Sopharma monthly feb 2012.doc Sopharma monthly feb 2012.doc | Sopharma monthly feb 2012 | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2012-03-05 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to None PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
